Asunto(s)
Carcinoma Mucoepidermoide/diagnóstico , Inmunoglobulina G/análisis , Neoplasias/diagnóstico , Neoplasias de la Parótida/diagnóstico , Esclerosis/diagnóstico , Adulto , Carcinoma Mucoepidermoide/patología , Diagnóstico Diferencial , Femenino , Humanos , Neoplasias/patología , Glándula Parótida/patología , Neoplasias de la Parótida/patología , Glándulas Salivales/patología , Esclerosis/patologíaRESUMEN
The aim of this study is to present the casuistic of mucoepidermoid carcinoma of salivary glands in patients diagnosed at Dr. Eduardo Cáceres Graziani National Institute for Neoplastic Diseases, Lima, Perú. From January 2002 to December 2012, 51 cases were diagnosed as mucoepidermoid carcinoma. The number of female patients was higher, with 28 cases (54.9%), and regarding age distribution, 33.3% of the patients were under 30 years old. Pain was one of the main symptoms, and 74.5% of the mucoepidermoid carcinomas were located in the parotid gland. It is concluded that epidemiology regarding age and gender of the 51 cases analyzed was in the same range as other studies, and that most cases were located in major salivary glands, in agreement with reports on other populations. Other characte ristics showed a homogeneous distribution.
El propósito de este estudio es presentar la casuística del carcinoma mucoepidermoide de glándulas salivales de pacientes diagnosticados en el Instituto Nacional de Enfermedades Neoplásicas Dr. Eduardo Cáceres Graziani Lima, Perú, desde el 2002 hasta el 2012. Realizamos un estudio retrospectivo en el cual fueron incluidos sujetos con diagnóstico primario de carcinoma mucoepidermoide en glándulas salivales. Entre enero de 2002 y diciembre de 2012, se registraron 51 casos. El número de pacientes de sexo femenino fue mayor, con 28 casos (54,9%) y con respecto a la distribución por edades, el 33,3% de los pacientes eran menores de 30 años de edad. El dolor fue uno de los síntomas principales. El 74,5% de los carcinomas mucoepidermoides se localizaron en la glándula parótida. De los hallazgos obtenidos se concluye principalmente que en lo que respecta a la distribución epidemiológica de edad y género de los 51 casos analizados estas variaron en el mismo rango de otros estudios. También se distingue que el mayor número de casos estuvieron localizados en glándulas salivales mayores, dato en concordancia con otras poblaciones reporta das. Las demás características presentaron una distribución homogénea.
Asunto(s)
Humanos , Masculino , Femenino , Carcinoma Mucoepidermoide/diagnóstico , Carcinoma Mucoepidermoide/epidemiología , Neoplasias de las Glándulas Salivales/clasificación , Neoplasias de las Glándulas Salivales/epidemiología , Distribución por Edad y Sexo , Biopsia/métodos , Diagnóstico Clínico , Diagnóstico Diferencial , Técnicas Histológicas , Perú , Pronóstico , Estudios Retrospectivos , Interpretación Estadística de DatosRESUMEN
CONTEXT: Necrotizing sialometaplasia is a benign, self-limited lesion of both major and minor salivary glands, although more commonly the latter. It can represent a diagnostic dilemma and may be mistaken for a malignant neoplasm, such as mucoepidermoid carcinoma, as well as invasive squamous cell carcinoma. A major causal relationship has been ascribed to ischemia. Bulimia, an eating disorder with increasing prevalence in our society, may also be an underlying underreported cause. OBJECTIVE: To discuss the potential pathogenesis, diagnostic pitfalls, and the application of immunohistochemistry as an aid in the diagnosis of necrotizing sialometaplasia. DATA SOURCES: This report uses a previously published case history for illustrative purposes and a review of the current literature. CONCLUSIONS: The diagnosis of necrotizing sialometaplasia may be difficult and is reliant upon a well-oriented biopsy section and a complete clinical history. Diagnosis may be further supplemented via immunohistochemistry, demonstrating focal to absent immunoreactivity for p53, low immunoreactivity for MIB1 (Ki-67), and the presence of 4A4/p63- and calponin-positive myoepithelial cells. Interpreted in context collectively, these findings may be helpful adjuncts in the diagnosis of necrotizing sialometaplasia; nonetheless, to date, hematoxylin-eosin staining remains the gold standard.
Asunto(s)
Glándulas Salivales/patología , Sialometaplasia Necrotizante/diagnóstico , Adulto , Biomarcadores/metabolismo , Bulimia/complicaciones , Bulimia/diagnóstico , Proteínas de Unión al Calcio/metabolismo , Carcinoma Mucoepidermoide/diagnóstico , Carcinoma de Células Escamosas/diagnóstico , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Proteínas de la Membrana/metabolismo , Proteínas de Microfilamentos/metabolismo , Neoplasias de las Glándulas Salivales/diagnóstico , Glándulas Salivales/metabolismo , Sialometaplasia Necrotizante/etiología , Sialometaplasia Necrotizante/metabolismo , CalponinasAsunto(s)
Neoplasias de los Bronquios/diagnóstico , Carcinoma Mucoepidermoide/diagnóstico , Anemia/etiología , Bronquios/patología , Bronquios/cirugía , Neoplasias de los Bronquios/complicaciones , Neoplasias de los Bronquios/terapia , Carcinoma Mucoepidermoide/complicaciones , Carcinoma Mucoepidermoide/terapia , Niño , Femenino , Humanos , Pulmón/diagnóstico por imagen , Pulmón/patología , Pulmón/cirugía , Masculino , Estadificación de Neoplasias , Pronóstico , Tomografía Computarizada por Rayos X , Resultado del TratamientoRESUMEN
BACKGROUND: High-dose radioiodine therapy following total thyroidectomy is standard for patients suffering from differentiated thyroid carcinoma and contributes significantly to their favourable prognosis. Due to active iodine accumulation, high focal radiation doses are received by the salivary glands. PATIENTS/RESULT: Report on two patients, who received multiple high-dose radioiodine treatments because of a differentiated metastatic thyroid carcinoma. A few years later, they developed a mucoepidermoid carcinoma of the salivary glands. Due to the high cumulative radiation dose, radiation-induced secondary malignancies following radiation-induced sialadenitis appears likely, although no causal connection could be proven. CONCLUSION: Consistent protection of the salivary glands during radioiodine therapy as well as the follow-up of the many long-term survivors of differentiated thyroid carcinomas is desirable to further lower the salivary gland-related side effects and to detect secondary malignancies as early as possible.